Logo image of SGRY

SURGERY PARTNERS INC (SGRY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SGRY - US86881A1007 - Common Stock

16.14 USD
+0.34 (+2.15%)
Last: 1/23/2026, 8:00:02 PM
16.14 USD
0 (0%)
After Hours: 1/23/2026, 8:00:02 PM
Fundamental Rating

3

Overall SGRY gets a fundamental rating of 3 out of 10. We evaluated SGRY against 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of SGRY while its profitability can be described as average. SGRY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year SGRY was profitable.
  • SGRY had a positive operating cash flow in the past year.
  • SGRY had negative earnings in each of the past 5 years.
  • SGRY had a positive operating cash flow in each of the past 5 years.
SGRY Yearly Net Income VS EBIT VS OCF VS FCFSGRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • The Return On Assets of SGRY (-2.16%) is comparable to the rest of the industry.
  • SGRY has a Return On Equity (-9.94%) which is in line with its industry peers.
  • The Return On Invested Capital of SGRY (5.57%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SGRY is below the industry average of 9.21%.
  • The last Return On Invested Capital (5.57%) for SGRY is above the 3 year average (5.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.16%
ROE -9.94%
ROIC 5.57%
ROA(3y)-1.04%
ROA(5y)-1.46%
ROE(3y)-4.24%
ROE(5y)-9.69%
ROIC(3y)5.03%
ROIC(5y)4.49%
SGRY Yearly ROA, ROE, ROICSGRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • SGRY's Operating Margin of 15.78% is amongst the best of the industry. SGRY outperforms 94.12% of its industry peers.
  • SGRY's Operating Margin has been stable in the last couple of years.
  • SGRY has a Gross Margin of 26.57%. This is comparable to the rest of the industry: SGRY outperforms 55.88% of its industry peers.
  • SGRY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.78%
PM (TTM) N/A
GM 26.57%
OM growth 3Y3.68%
OM growth 5Y1.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y-0.73%
SGRY Yearly Profit, Operating, Gross MarginsSGRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • SGRY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • SGRY has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SGRY has been increased compared to 5 years ago.
  • The debt/assets ratio for SGRY is higher compared to a year ago.
SGRY Yearly Shares OutstandingSGRY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SGRY Yearly Total Debt VS Total AssetsSGRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.76, we must say that SGRY is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.76, SGRY is not doing good in the industry: 74.51% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of SGRY is 18.37, which is on the high side as it means it would take SGRY, 18.37 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 18.37, SGRY is in line with its industry, outperforming 41.18% of the companies in the same industry.
  • A Debt/Equity ratio of 2.00 is on the high side and indicates that SGRY has dependencies on debt financing.
  • SGRY has a worse Debt to Equity ratio (2.00) than 72.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 18.37
Altman-Z 0.76
ROIC/WACC0.63
WACC8.85%
SGRY Yearly LT Debt VS Equity VS FCFSGRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • SGRY has a Current Ratio of 1.88. This is a normal value and indicates that SGRY is financially healthy and should not expect problems in meeting its short term obligations.
  • SGRY has a better Current ratio (1.88) than 78.43% of its industry peers.
  • A Quick Ratio of 1.72 indicates that SGRY should not have too much problems paying its short term obligations.
  • The Quick ratio of SGRY (1.72) is better than 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.72
SGRY Yearly Current Assets VS Current LiabilitesSGRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • SGRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.02%.
  • Looking at the last year, SGRY shows a quite strong growth in Revenue. The Revenue has grown by 10.14% in the last year.
  • Measured over the past years, SGRY shows a quite strong growth in Revenue. The Revenue has been growing by 11.20% on average per year.
EPS 1Y (TTM)-17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.58%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y11.86%
Revenue growth 5Y11.2%
Sales Q2Q%6.63%

3.2 Future

  • SGRY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.89% yearly.
  • Based on estimates for the next years, SGRY will show a small growth in Revenue. The Revenue will grow by 7.88% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-10.69%
EPS Next 3Y0.93%
EPS Next 5Y12.89%
Revenue Next Year6.88%
Revenue Next 2Y7.52%
Revenue Next 3Y7.62%
Revenue Next 5Y7.88%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SGRY Yearly Revenue VS EstimatesSGRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
SGRY Yearly EPS VS EstimatesSGRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 -2

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.69 indicates a rather expensive valuation of SGRY.
  • Based on the Price/Earnings ratio, SGRY is valued a bit cheaper than 71.57% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SGRY to the average of the S&P500 Index (27.21), we can say SGRY is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 21.53, which indicates a rather expensive current valuation of SGRY.
  • SGRY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SGRY is cheaper than 60.78% of the companies in the same industry.
  • SGRY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.69
Fwd PE 21.53
SGRY Price Earnings VS Forward Price EarningsSGRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SGRY is valued a bit cheaper than the industry average as 78.43% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, SGRY is valued cheaper than 85.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.76
EV/EBITDA 8.38
SGRY Per share dataSGRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.69%
EPS Next 3Y0.93%

0

5. Dividend

5.1 Amount

  • SGRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SURGERY PARTNERS INC / SGRY FAQ

Can you provide the ChartMill fundamental rating for SURGERY PARTNERS INC?

ChartMill assigns a fundamental rating of 3 / 10 to SGRY.


What is the valuation status for SGRY stock?

ChartMill assigns a valuation rating of 4 / 10 to SURGERY PARTNERS INC (SGRY). This can be considered as Fairly Valued.


How profitable is SURGERY PARTNERS INC (SGRY) stock?

SURGERY PARTNERS INC (SGRY) has a profitability rating of 4 / 10.


What is the financial health of SURGERY PARTNERS INC (SGRY) stock?

The financial health rating of SURGERY PARTNERS INC (SGRY) is 2 / 10.


What is the earnings growth outlook for SURGERY PARTNERS INC?

The Earnings per Share (EPS) of SURGERY PARTNERS INC (SGRY) is expected to decline by -29.92% in the next year.